Failure of High Doses of Propranolol to Reduce Experimental Myocardial Ischemic Damage

Circulation - United States
doi 10.1161/01.cir.57.3.534
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Autoantibodies Against 3-Adrenoceptor Reduce the Susceptibility to Myocardial Ischemic/Reperfusion Injury of Heart Failure Rats

Heart
Cardiovascular MedicineCardiology
2011English

Inflammatory Reactions in Experimental Myocardial Damage

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic From Non-Ischemic End Stage Heart Failure

PLoS ONE
Multidisciplinary
2014English

Experimental Studies on Ischemic Acute Renal Failure

Japanese Journal of Urology
Urology
1987English

Pharmacodynamics of Propranolol in Renal Failure

American Heart Journal
Cardiovascular MedicineCardiology
1973English

Pharmacodynamics of Propranolol in Renal Failure

BMJ
1972English

Trial of Propranolol in Acute Myocardial Infarction.

BMJ
1968English

Mechanisms of Ischemic Myocardial Cell Damage Assessed by Phosphorus-31 Nuclear Magnetic Resonance

Circulation
Cardiovascular MedicinePhysiologyCardiology
1982English

Failure of Montelukast to Reduce Sputum Eosinophilia in High-Dose Corticosteroid-Dependent Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy